Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 53 medicines
CBG-MEB · 44 medicines
MS · 24 medicines · Historical list
SFDA · 18 medicines · Historical list
AIFA · 17 medicines
ALIMS · 15 medicines
HSA · 12 medicines
FDA · 9 medicines
HALMED · 5 medicines
PHARMAC · 3 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
82 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| GABAPENTINA CINFA 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| GABAPENTINA CINFA 400 mg CAPSULAS DURAS EFG | Spain | 400 mg | cápsula dura | Marketed | Laboratorios Cinfa S.A. |
| GABAPENTINA TEVA 100 mg CAPSULAS DURAS EFG | Spain | 100 mg | cápsula dura | Marketed | Teva Pharma S.L.U. |
| GABAPENTINA ALMUS 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Almus Farmaceutica S.A.U. |
| GABAPENTINA ALMUS 400 mg CAPSULAS DURAS EFG | Spain | 400 mg | cápsula dura | Marketed | Almus Farmaceutica S.A.U. |
| GABAPENTINA ALTER 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Laboratorios Alter S.A. |
| GABAPENTINA ALTER 400 mg CAPSULAS DURAS EFG | Spain | 400 mg | cápsula dura | Marketed | Laboratorios Alter S.A. |
| Gabapentina Combix 300 MG Capsulas Duras Efg | Spain | 300 mg | cápsula dura | Marketed | Laboratorios Combix S.L.U. |
| Gabapentina Combix 400 MG Capsulas Duras Efg | Spain | 400 mg | cápsula dura | Marketed | Laboratorios Combix S.L.U. |
| GABAPENTINA STADA 300 mg CAPSULAS DURAS EFG | Spain | 300,00 mg | cápsula dura | Marketed | Laboratorio Stada S.L. |
| GABAPENTINA STADA 400 mg CAPSULAS DURAS EFG | Spain | 400,00 mg | cápsula dura | Marketed | Laboratorio Stada S.L. |
| GABAPENTINA NORMON 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Laboratorios Normon S.A. |
| GABAPENTINA NORMON 400 mg CAPSULAS DURAS EFG | Spain | 400 mg | cápsula dura | Marketed | Laboratorios Normon S.A. |
| GABAPENTINA SANDOZ 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Sandoz Farmaceutica S.A. |
| GABAPENTINA SANDOZ 400 mg CAPSULAS DURAS EFG | Spain | 400 mg | cápsula dura | Marketed | Sandoz Farmaceutica S.A. |
| Gabapentina Tarbis 100 MG Capsulas Duras Efg | Spain | 100 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Gabapentina Tarbis 300 MG Capsulas Duras Efg | Spain | 300 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| Gabapentina Tarbis 400 MG Capsulas Duras Efg | Spain | 400 mg | cápsula dura | Marketed | Tarbis Farma S.L. |
| GABAPENTINA TEVAGEN 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Teva Pharma S.L.U. |
| GABAPENTINA TEVAGEN 400 mg CAPSULAS DURAS EFG | Spain | 400 mg | cápsula dura | Marketed | Teva Pharma S.L.U. |
| Gabapentina Aurovitas 300 MG Capsulas Duras Efg | Spain | 300,00 mg | cápsula dura | Marketed | Aurovitas Spain, S.A.U. |
| Gabapentina Aurovitas 400 MG Capsulas Duras Efg | Spain | 400,00 mg | cápsula dura | Marketed | Aurovitas Spain, S.A.U. |
| GABAPENTINA TECNIGEN 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Tecnimede España Industria Farmaceutica S.A. |
| GABAPENTINA TECNIGEN 400 mg CAPSULAS DURAS EFG | Spain | 400 mg | cápsula dura | Marketed | Tecnimede España Industria Farmaceutica S.A. |
| GABAPENTINA KERN PHARMA 300 mg CAPSULAS DURAS EFG | Spain | 300 mg | cápsula dura | Marketed | Kern Pharma S.L. |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
Guidelines in the library that name this substance.
Recent articles that name this substance.
